Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Repaglinide 135062-02-1 100mg
SDP

Catalog No. 502240501
Encompass_Preferred

Repaglinide (CAS 135062-02-1) is a small-molecule modulator that acts as a blocker of ATP-sensitive potassium (K sub ATP /sub ) channels specifically binding with high affinity to the sulfonylurea receptor 1 (SUR1) subunit when co-expressed with K sub ir /sub 6 2 (K sub d /sub 0 42 nM) Through inhibition of K sub ATP /sub channel activity repaglinide promotes membrane depolarization and subsequent insulin secretion from pancreatic -cells In vivo studies demonstrate its glucose-lowering (hypoglycaemic) effects supporting its utility in antidiabetic research and in mechanistic investigations of pancreatic K sub ATP /sub channel regulation

This item is not returnable. View return policy
Catalog No. 50-224-0501 Supplier Apexbio Technology LLC Supplier No. A5316100
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Repaglinide (CAS 135062-02-1) is a small-molecule modulator that acts as a blocker of ATP-sensitive potassium (K sub ATP /sub ) channels specifically binding with high affinity to the sulfonylurea receptor 1 (SUR1) subunit when co-expressed with K sub ir /sub 6 2 (K sub d /sub 0 42 nM) Through inhibition of K sub ATP /sub channel activity repaglinide promotes membrane depolarization and subsequent insulin secretion from pancreatic -cells In vivo studies demonstrate its glucose-lowering (hypoglycaemic) effects supporting its utility in antidiabetic research and in mechanistic investigations of pancreatic K sub ATP /sub channel regulation

This item is not returnable. View return policy
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.